Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects

OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.

Saved in:
Bibliographic Details
Main Authors: George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, the Canadian Carbapenem Discussion Group
Format: Article
Language:English
Published: Wiley 1998-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1998/831425
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524597454798848
author George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
author_facet George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
author_sort George G Zhanel
collection DOAJ
description OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.
format Article
id doaj-art-05271c1cb6f742008391b2c991973ab2
institution Kabale University
issn 1180-2332
language English
publishDate 1998-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases
spelling doaj-art-05271c1cb6f742008391b2c991973ab22025-02-03T05:47:50ZengWileyCanadian Journal of Infectious Diseases1180-23321998-01-019421522810.1155/1998/831425Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse EffectsGeorge G Zhanel0Andrew E Simor1Lavern Vercaigne2Lionell Mandell3the Canadian Carbapenem Discussion GroupDepartments of Medicine and Microbiology, Health Sciences Centre and Faculties of Pharmacy and Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, CanadaDepartment of Pharmacy, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Infectious Diseases, McMaster University, Hamilton, Ontario, CanadaOBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.http://dx.doi.org/10.1155/1998/831425
spellingShingle George G Zhanel
Andrew E Simor
Lavern Vercaigne
Lionell Mandell
the Canadian Carbapenem Discussion Group
Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
Canadian Journal of Infectious Diseases
title Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_full Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_fullStr Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_full_unstemmed Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_short Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
title_sort imipenem and meropenem comparison of in vitro activity pharmacokinetics clinical trials and adverse effects
url http://dx.doi.org/10.1155/1998/831425
work_keys_str_mv AT georgegzhanel imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT andrewesimor imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT lavernvercaigne imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT lionellmandell imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects
AT thecanadiancarbapenemdiscussiongroup imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects